A new hypothesis on the manifestation of cerebral malaria: The secret is in the liver

Medical Hypotheses

Volumn 81, Issue 5, 2013, Pages 777-783

  Martins, Yuri Chaves ^a,b   Daniel Ribeiro, Cláudio Tadeu ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LIVER FAILURE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOTTING DISORDER; BRAIN MALARIA; BRAIN METABOLISM; CLINICAL FEATURE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER; LIVER DISEASE; LIVER INJURY; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; THROMBOCYTOPENIA;

MURINAE; MUS; PLASMODIUM FALCIPARUM;

BLOOD-BRAIN BARRIER; ERYTHROCYTES; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MALARIA, CEREBRAL; MODELS, BIOLOGICAL; PLASMODIUM FALCIPARUM;

EID: 84886785674     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.08.005     Document Type: Article

References (102)

1. WHO. World malaria report: 2012 In: W.H. Organization, editor. WHO Press, Geneva, 2012, p. 105.
2. Severe falciparum malaria World Health Organization communicable diseases cluster. Trans R Soc Trop Med Hyg 2000, 94(Suppl. 1):S1-S90.
3. Mwanga-Amumpaire J., Ndeezi G., Tumwine J.K. Effect of vitamin A adjunct therapy for cerebral malaria in children admitted to Mulago hospital: a randomized controlled trial. Af Health Sci 2012, 12:90-97.
4. Mohanty S., Mishra S.K., Patnaik R., et al. Brain swelling and mannitol therapy in adult cerebral malaria: a randomized trial. Clin Inf Dis 2011, 53:349-355.
5. Richardson E.D., Varney N.R., Roberts R.J., Springer J.A., Wood P.S. Long-term cognitive sequelae of cerebral malaria in Vietnam veterans. App Neuropsychol 1997, 4:238-243.
6. Boivin M.J., Bangirana P., Byarugaba J., et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 2007, 119:e360-366.
7. John C.C., Bangirana P., Byarugaba J., et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 2008, 122:e92-99.
8. Martins Y.C., Carvalho L.J., Daniel-Ribeiro C.T. Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation 2009, 16:134-145.
9. Idro R., Jenkins N.E., Newton C.R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005, 4:827-840.
10. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol Today 1994, 10:410-412.
11. Berendt A.R., Tumer G.D., Newbold C.I. Cerebral malaria: the sequestration hypothesis. Parasitol Today 1994, 10:412-414.
12. van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006, 22:503-508.
13. Higgins S.J., Kain K.C., Liles W.C. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti-Infect Ther 2011, 9:803-819.
14. Dondorp A.M., Kager P.A., Vreeken J., White N.J. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol Today 2000, 16:228-232.
15. Springer A.L., Smith L.M., Mackay D.Q., Nelson S.O., Smith J.D. Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Mol Biochem Parasitol 2004, 137:55-64.
16. Sherman I.W., Crandall I., Smith H. Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocytes to the endothelium. Biol Cell/under the auspices of the European Cell Biology Organization 1992, 74:161-178.
17. Claessens A., Adams Y., Ghumra A., et al. A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc Natl Acad Sci USA 2012, 109:E1772-1781.
18. Ochola L.B., Siddondo B.R., Ocholla H., et al. Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PloS one 2011, 6:e14741.
19. Deloron P., Dumont N., Nyongabo T., et al. Immunologic and biochemical alterations in severe falciparum malaria: relation to neurological symptoms and outcome. Clin Inf Dis 1994, 19:480-485.
20. von Seidlein L., Olaosebikan R., Hendriksen I.C., et al. Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Inf Dis 2012, 54:1080-1090.
21. Eling W.M., Kremsner P.G. Cytokines in malaria, pathology and protection. Biotherapy 1994, 7:211-221.
22. Clark I.A., Cowden W.B. The pathophysiology of falciparum malaria. Pharmacol Ther 2003, 99:221-260.
23. Thapa R., Patra V., Kundu R. Plasmodium vivax cerebral malaria. Indian Pediatr 2007, 44:433-434.
24. Rogerson S.J., Carter R. Severe vivax malaria: newly recognised or rediscovered. PLoS Med 2008, 5:e136.
25. Mahgoub H., Gasim G.I., Musa I.R., Adam I. Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan. Parasites Vectors 2012, 5:154.
26. Tanwar G.S., Khatri P.C., Sengar G.S., et al. Clinical profiles of 13 children with Plasmodium vivax cerebral malaria. Ann Trop Paediatr 2011, 31:351-356.
27. Cabrales P., Zanini G.M., Meays D., Frangos J.A., Carvalho L.J. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 2010, 176:1306-1315.
28. Clark I.A., Alleva L.M. Is human malarial coma caused, or merely deepened, by sequestration?. Trends Parasitol 2009, 25:314-318.
29. Gazzinelli R.T., Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006, 6:895-906.
30. Nebl T., De Veer M.J., Schofield L. Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors. Parasitology 2005, 130(Suppl.):S45-62.
31. Ferreira A., Balla J., Jeney V., Balla G., Soares M.P. A central role for free heme in the pathogenesis of severe malaria: the missing link?. J Mol Med 2008, 86:1097-1111.
32. Hunt N.H., Golenser J., Chan-Ling T., et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006, 36:569-582.
33. Gramaglia I., Sobolewski P., Meays D., et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 2006, 12:1417-1422.
34. Pamplona A., Ferreira A., Balla J., et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 2007, 13:703-710.
35. Nitcheu J., Bonduelle O., Combadiere C., et al. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003, 170:2221-2228.
36. Machado F.S., Desruisseaux M.S., Nagajyothi, et al. Endothelin in a murine model of cerebral malaria. Expl Biol Med (Maywood, N.J.) 2006, 231:1176-1181.
37. Dai M., Freeman B., Bruno F.P., et al. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative. Life Sci 2012, 91:687-692.
38. Wenisch C., Wenisch H., Wilairatana P., et al. Big endothelin in patients with complicated Plasmodium falciparum malaria. J Infect Dis 1996, 173:1281-1284.
39. de Souza J.B., Riley E.M. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect/Institut Pasteur 2002, 4:291-300.
40. Coltel N., Combes V., Wassmer S.C., Chimini G., Grau G.E. Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect/Institut Pasteur 2006, 8:2305-2316.
41. Haque A., Echchannaoui H., Seguin R., Schwartzman J., Kasper L.H., Haque S. Cerebral malaria in mice: interleukin-2 treatment induces accumulation of gammadelta T cells in the brain and alters resistant mice to susceptible-like phenotype. Am J Pathol 2001, 158:163-172.
42. Hemmer C.J., Holst F.G., Kern P., Chiwakata C.B., Dietrich M., Reisinger E.C. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006, 11:817-823.
43. van Hensbroek M.B., Palmer A., Onyiorah E., et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 1996, 174:1091-1097.
44. Prasad K., Garner P. Steroids for treating cerebral malaria. Cochrane Database Syst Rev (Online) 2000, 2:CD000972.
45. Medana I.M., Day N.P., Sachanonta N., et al. Coma in fatal adult human malaria is not caused by cerebral oedema. Malaria J 2011, 10:267.
46. Lee W.M. Recent developments in acute liver failure. Best Pract Res. Clin Gastroenterol 2012, 26:3-16.
47. Shawcross D.L., Wendon J.A. The neurological manifestations of acute liver failure. Neurochem Int 2012, 60:662-671.
48. Desjardins P., Du T., Jiang W., Peng L., Butterworth R.F. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int 2012, 60:690-696.
49. Kochar D.K., Tanwar G.S., Khatri P.C., et al. Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am J Trop Med Hyg 2010, 83:981-989.
50. Mohanty N., Satpathy S.K., Nanda P. Hepatopathy in complicated falciparum malaria: report from eastern India. Trans R Soc Trop Med Hyg 2004, 98:753-754.
51. Autino B., Corbett Y., Castelli F., Taramelli D. Pathogenesis of malaria in tissues and blood. Mediterr J Hematol Infect Dis 2012, 4:e2012061.
52. Anand A.C., Puri P. Jaundice in malaria. J Gastroenterol Hepatol 2005, 20:1322-1332.
53. Whitten R., Milner D.A., Yeh M.M., Kamiza S., Molyneux M.E., Taylor T.E. Liver pathology in Malawian children with fatal encephalopathy. Hum Pathol 2011, 42:1230-1239.
54. Waller D., Krishna S., Crawley J., et al. Clinical features and outcome of severe malaria in Gambian children. Clin Inf Dis 1995, 21:577-587.
55. Wilairatana P., Looareesuwan S., Charoenlarp P. Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop Med Parasitol 1994, 45:298-302.
56. Nacher M., Treeprasertsuk S., Singhasivanon P., et al. Association of hepatomegaly and jaundice with acute renal failure but not with cerebral malaria in severe falciparum malaria in Thailand. Am J Trop Med Hyg 2001, 65:828-833.
57. Prommano O., Chaisri U., Turner G.D., et al. A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malaria. Southeast Asian J Trop Med Public Health 2005, 36:1359-1370.
58. Medana I.M., Turner G.D. Human cerebral malaria and the blood-brain barrier. Int J Parasitol 2006, 36:555-568.
59. Haque A., Best S.E., Amante F.H., et al. High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology. Infect Immun 2011, 79:1882-1888.
60. Martins Y.C., Smith M.J., Pelajo-Machado M., et al. Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. Int J Exp Pathol 2009, 90:119-130.
61. De-Oliveira A.C., Da-Matta A.C., Paumgartten F.J. Plasmodium berghei (ANKA): infection induces CYP2A5 and 2E1 while depressing other CYP isoforms in the mouse liver. Exp Parasitol 2006, 113:256-261.
62. Jacobs T., Plate T., Gaworski I., Fleischer B. CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria. Eur J Immunol 2004, 34:972-980.
63. Penet M.F., Viola A., Confort-Gouny S., et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci 2005, 25:7352-7358.
64. Ghosh S., Sengupta A., Sharma S., Sonawat H.M. Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a (1)H NMR spectroscopy-based metabonomic study. J Proteome Res 2012, 11:4992-5004.
65. Sanni L.A., Rae C., Maitland A., Stocker R., Hunt N.H. Is ischemia involved in the pathogenesis of murine cerebral malaria?. Am J Pathol 2001, 159:1105-1112.
66. Promeneur D., Lunde L.K., Amiry-Moghaddam M., Agre P. Protective role of brain water channel AQP4 in murine cerebral malaria. Proc Natl Acad Sci USA 2013, 110:1035-1040.
67. Hafalla J.C., Claser C., Couper K.N., et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog 2012, 8:e1002504.
68. Jacobs T., Graefe S.E., Niknafs S., Gaworski I., Fleischer B. Murine malaria is exacerbated by CTLA-4 blockade. J Immunol 2002, 169:2323-2329.
69. Fauconnier M., Palomo J., Bourigault M.L., et al. IL-12Rbeta2 is essential for the development of experimental cerebral malaria. J Immunol 2012, 188:1905-1914.
70. Villegas-Mendez A., de Souza J.B., Murungi L., et al. Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol 2011, 187:2885-2897.
71. Marquet S., Doumbo O., Cabantous S., et al. A functional promoter variant in IL12B predisposes to cerebral malaria. Hum Mol Genet 2008, 17:2190-2195.
72. Nagamine Y., Hayano M., Kashiwamura S., et al. Involvement of interleukin-18 in severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2003, 97:236-241.
73. Adachi K., Tsutsui H., Seki E., et al. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice. Int Immunol 2004, 16:787-798.
74. Dey S., Bindu S., Goyal M., et al. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free heme overload, NF-kappaB activation, and neutrophil infiltration. J Biol Chem 2012, 287:26630-26646.
75. Mastelic B., do Rosario A.P., Veldhoen M., et al. IL-22 protects against liver pathology and lethality of an experimental blood-stage malaria infection. Front Immunol 2012, 3:85.
76. Findlay E.G., Greig R., Stumhofer J.S., et al. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol 2010, 185:2482-2492.
77. Adachi K., Tsutsui H., Kashiwamura S., et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J Immunol 2001, 167:5928-5934.
78. Moxon C.A., Heyderman R.S., Wassmer S.C. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol 2009, 166:99-108.
79. Lisman T., Porte R.J. Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost 2010, 36:437-443.
80. Pino P., Taoufiq Z., Nitcheu J., Vouldoukis I., Mazier D. Blood-brain barrier breakdown during cerebral malaria: suicide or murder?. Thromb Haemost 2005, 94:336-340.
81. Adams S., Brown H., Turner G. Breaking down the blood-brain barrier: signaling a path to cerebral malaria?. Trends Parasitol 2002, 18:360-366.
82. Gay F., Zougbede S., N'Dilimabaka N., Rebollo A., Mazier D., Moreno A. Cerebral malaria: what is known and what is on research. Revue neurologique 2012, 168:239-256.
83. Adam N., Kandelman S., Mantz J., Chretien F., Sharshar T. Sepsis-induced brain dysfunction. Expert Rev Anti-Inf Ther 2013, 11:211-221.
84. Huber J.D., Egleton R.D., Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001, 24:719-725.
85. Bertinaria M., Guglielmo S., Rolando B., et al. Amodiaquine analogues containing NO-donor substructures: synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria. Eur J Med Chem 2011, 46:1757-1767.
86. Martins Y.C., Clemmer L., Orjuela-Sanchez P., et al. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria. Malaria J 2013, 12:138.
87. Martins Y.C., Zanini G.M., Frangos J.A., Carvalho L.J. Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. PloS one 2012, 7:e32048.
88. Zanini G.M., Martins Y.C., Cabrales P., Frangos J.A., Carvalho L.J. S-nitrosoglutathione prevents experimental cerebral malaria. J Neuroimmune Pharmacol 2012, 7:477-487.
89. Sorensen M. Update on cerebral uptake of blood ammonia. Metab Brain Dis 2013, 28:155-159.
90. Lacerda-Queiroz N., Lima O.C., Carneiro C.M., et al. Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: an intravital microscopic study. Acta Tropica 2011, 120:31-39.
91. Penet M.F., Kober F., Confort-Gouny S., et al. Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with Plasmodium berghei ANKA. J Biol Chem 2007, 282:14505-14514.
92. Ott P., Larsen F.S. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 2004, 44:185-198.
93. Carvalho L.J. Murine cerebral malaria: how far from human cerebral malaria?. Trends Parasitol 2010, 26:271-272.
94. White N.J., Turner G.D., Medana I.M., Dondorp A.M., Day N.P. The murine cerebral malaria phenomenon. Trends Parasitol 2010, 26:11-15.
95. Marin-Menendez A., Bardaji A., Martinez-Espinosa F.E., et al. Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis 2013, 7:e2155.
96. Carvalho B.O., Lopes S.C., Nogueira P.A., et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis 2010, 202:638-647.
97. Costa F.T., Lopes S.C., Albrecht L., et al. On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field. Int J Parasitol 2012, 42:1099-1105.
98. Charunwatthana P., Abul Faiz M., Ruangveerayut R., et al. N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit Care Med 2009, 37:516-522.
99. Barcus M.J., Hien T.T., White N.J., et al. Short report: hepatitis b infection and severe Plasmodium falciparum malaria in Vietnamese adults. Am J Trop Med Hyg 2002, 66:140-142.
100. Suidan G.L., McDole J.R., Chen Y., Pirko I., Johnson A.J. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PloS one 2008, 3:e3037.
101. Nitta T., Hata M., Gotoh S., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660.
102. Saitou M., Furuse M., Sasaki H., et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000, 11:4131-4142.